Search by Drug Name or NDC

    NDC 00404-9993-02 ADENOSINE 3 mg/mL Details

    ADENOSINE 3 mg/mL

    ADENOSINE is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Henry Schein, Inc.. The primary component is ADENOSINE.

    Product Information

    NDC 00404-9993
    Product ID 0404-9993_ee202dbf-63f9-4ca9-8131-c88b6b374ff1
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name ADENOSINE
    Proprietary Name Suffix n/a
    Non-Proprietary Name adenosine injection, solution
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 3
    Active Ingredient Units mg/mL
    Substance Name ADENOSINE
    Labeler Name Henry Schein, Inc.
    Pharmaceutical Class Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077133
    Listing Certified Through 2024-12-31

    Package

    NDC 00404-9993-02 (00404999302)

    NDC Package Code 0404-9993-02
    Billing NDC 00404999302
    Package 1 VIAL, SINGLE-USE in 1 BAG (0404-9993-02) / 2 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2023-06-28
    NDC Exclude Flag N
    Pricing Information N/A